4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Balaxi Pharmaceuticals Limited (BALAXI) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Hyderabad, India. Its market capitalization is roughly ₹1 billion. In the fiscal year ended 2026-03-31, BALAXI reported ₹2.7B in revenue and ₹14M in net income.
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹2.7B | ₹2.9B | ₹2.4B | ₹3.4B | — |
| Gross Profit | ₹1.2B | ₹1.3B | ₹1.1B | ₹1.3B | — |
| Operating Income (EBIT) | ₹75M | ₹364M | ₹458M | ₹557M | — |
| Net Income | ₹14M | ₹251M | (₹24M) | ₹460M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹807M | ₹707M | ₹725M | ₹562M | ₹707M | — |
| Gross Profit | ₹375M | ₹302M | ₹308M | ₹272M | ₹312M | — |
| Operating Income (EBIT) | ₹38M | (₹5M) | ₹25M | ₹7M | ₹37M | — |
| Net Income | ₹13M | ₹6M | ₹3M | ₹2M | ₹3M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | (₹5M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹3.4B | ₹3.1B | ₹2.6B | ₹2.4B | — |
| Total Liabilities | ₹880M | ₹786M | ₹570M | ₹568M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BALAXI viewer.
About TickerBase · Data methodology & sources · Privacy · Terms